KOREA WHO

Yoon Sung-tae is the Chairman of Huons Global.

After stepping down as CEO of Huons Global in 2022, he took on the role of CEO at Huons Lab, one of the group's subsidiaries. In other subsidiaries, including Huons Global, he serves as an inside director or non-executive director.

As the second-generation owner, Yoon Sung-tae is the son of the late Yoon Myung-yong, the founder of Huons.

Yoon Sung-tae was born on July 13, 1964, in Asan, Chungcheongnam-do.

He graduated from Inchang High School in Seoul and earned a bachelor's degree in Industrial Engineering from Hanyang University, followed by a master's degree in Project Management from Hanyang University's Graduate School of Engineering.

After working at IBM Korea, he joined Kwangmyung Pharmaceutical, the predecessor of Huons, in 1992.

In 1997, following the sudden passing of his father, he took over the family business and became CEO. In 2016, he became the CEO of Huons Global, the holding company, and in 2022, he was appointed Chairman of Huons Global.

During his tenure, he grew the company from a business with KRW 6 billion (US$ 4.3 million) in revenue to a large healthcare group with revenue in the KRW 700 billion (US$ 504.7 million) range.

Yoon is recognized as an expert in mergers and acquisitions (M&A) and emphasizes a management style focused on harmony among people.

He has built the business around a "trinity" of pharmaceuticals, health functional foods, and aesthetics, directing the subsidiaries to grow based on mutual synergies.

#YoonSungtae #HuonsGlobal #healthcare #pharmaceuticals #businessleadership #SouthKorea #M&A #HuonsLab #familybusiness #aesthetics